IVD News and Research

RSS

New Study Compares MALDI-TOF MS Assays for Detecting Carbapenemase Activity

Austrian researchers evaluate MALDI-TOF MS assays for carbapenemase detection, assessing their reliability and practicality in managing resistant infections.

18 Nov 2024

Aidian is Now An IVDR Certified Company

We are proud to announce that Aidian has successfully achieved IVDR (In Vitro Diagnostic Regulation) certification, which was granted by notified body TüV SüD Product Service GmbH.

From Aidian Oy 20 Sep 2024

AMLo Biosciences Receives UKCA Mark for Groundbreaking Melanoma Biomarker Test

AMLo Biosciences Ltd (Newcastle upon Tyne, UK) announces the successful receipt of the UKCA mark for AMBLor. AMBLor is a groundbreaking histopathological biomarker test for the personal identification of early-stage melanomas at low risk of progression, post staging diagnosis.

6 Sep 2024

Enhancing Laboratory Performance with Comprehensive HIL Monitoring

The release of the new version of ISO 15189 (2022), introduced increased focus on risk stratification and mitigation for patients and laboratory stakeholders as well as more emphasis on quality control to improve accuracy and validity of results. Interference caused by hemolysis, icterus and lipemia is responsible for many rejected results and incorrect diagnosis. It is therefore of the upmost importance to accurately capture the presence of interfering substances in samples before quantitative analysis is carried out.

29 Jul 2024

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S.

From Qiagen 9 Jan 2024

Re-defining the limits of single batch assay stabilisation

In response to increasing demand for stabilised molecular diagnostic assays, we have significantly increased our single batch lyophilised reagent bead manufacturing throughput to 300,000 reactions per freeze drying run and are now progressing towards a capacity of 100 million tests per annum.

From Biofortuna Limited 22 Aug 2022

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

MIP Diagnostics, a leading UK nanotechnology firm has today rebranded to MIP Discovery as the business continues its expansion within the healthcare sector.

From MIP Discovery 19 May 2022

The Nucleic Acid Experts – Certified Twice!

BioEcho Life Sciences receives two important hallmarks for its quality management – DIN EN ISO 9001:2015 and DIN EN ISO 13485:2016.

From BioEcho Life Sciences GmbH 10 Mar 2022

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Mercia Asset Management, Calculus Capital, Downing Ventures and BGF scale joint investment in latest fundraise.

From MIP Discovery 1 Mar 2022

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease

17 Feb 2022

Expanded range of nucleic acid extraction kits for pathogens detection

AMSBIO announce the addition of several new products to its growing range of magnetic bead based nucleic acid extraction kits for pathogens detection.

From AMS Biotechnology 9 Feb 2022

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta and Gamma variants of the COVID-19 virus.

14 Jan 2022

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics has today announced the launch of its novel Molecular Imprinting Epitope Discovery Service.

26 Oct 2021

New research sheds light on the working principles of advanced biosensing technologies

The COVID-19 pandemic is undoubtedly the most challenging global health burden since the 2nd World War. The pandemic has raised social awareness on the importance of effective and timely diagnosis that may help minimize the risk of contracting and spreading COVID-19.

22 Oct 2020